111, Inc. - American Depositary Shares (YI)

Competitors to 111, Inc. - American Depositary Shares (YI)

Aphria Inc.

Aphria Inc., specializing in the production and distribution of medical cannabis, competes with 111, Inc. through its extensive portfolio of cannabis products and strong international presence. With a focus on optimizing production efficiency and cost-effectiveness, Aphria has established a competitive advantage that makes it a strong contender against 111, Inc., particularly in the medical use market.

Cansortium Inc.

Cansortium Inc. operates in the same cannabis sector as 111, Inc., focusing on the cultivation and processing of cannabis products. While both companies aim to capitalize on the growing cannabis market, Cansortium’s established presence in various U.S. states and its extensive distribution network provide it with a competitive advantage in terms of market reach and brand recognition.

Curaleaf Holdings, Inc.

Curaleaf Holdings is another major player in the cannabis industry, emphasizing vertically integrated operations across cultivation, processing, and retail. Compared to 111, Inc., Curaleaf has a significant scale and breadth of products available, which helps it maintain leadership in market share and customer outreach, thus presenting a strong competitive challenge to 111, Inc.

Zylo Therapeutics

Zylo Therapeutics focuses on drug delivery systems and innovative formulations, which directly competes with 111, Inc.'s focus on the healthcare and biotechnology sectors. Both companies leverage technology and research to develop competitive pharmaceutical products, although Zylo has a particular specialization in targeted therapies and has established partnerships with larger pharmaceutical firms which enhance their market position.